Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.

MLA

Kamperman, R. G., et al. “Does COVID-19 Impact the Prevalence of Myositis Specific Antibodies in the Netherlands? A Comparative Nationwide Study.” Journal of Autoimmunity, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1399414425&authtype=sso&custid=ns315887.

APA

Kamperman, R. G., Leeuwen, E. M. van, Willems, M., Kooi, A. J. van der, Gelderman, K. A., Hamann, D., Lochem, E. G. van, Meek, B., Molen, R. G. van der, Platteel, A. C., Otten, H. G., Schreurs, M. W., & Raaphorst, J. (2023). Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. Journal of Autoimmunity.

Chicago

Kamperman, R.G., E.M. van Leeuwen, M. Willems, A.J. van der Kooi, K.A. Gelderman, D. Hamann, E.G. van Lochem, et al. 2023. “Does COVID-19 Impact the Prevalence of Myositis Specific Antibodies in the Netherlands? A Comparative Nationwide Study.” Journal of Autoimmunity. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1399414425&authtype=sso&custid=ns315887.